Affiliation:
1. Department of Neurology, Albert Szent‐Györgyi Clinical Centre, Albert Szent‐Györgyi Faculty of Medicine University of Szeged Szeged Hungary
2. Department of Neurology Elbe Klinik Stade Stade Germany
Abstract
AbstractBackgroundDue to its heterogeneous manifestation an individualized approach to reach therapeutic goals in cervical dystonia (CD) is advantageous.ObjectivesThe aim of the current study was to adapt goal attainment scaling (GAS) to drive the management of CD.Methods38 patients with CD, regularly treated with botulinum neurotoxin (BoNT), were involved in the current exploratory observational pilot study. GAS, including domains of motor, pain, disability, and psychiatric features, was applied to set up individualized goals with the calculation of initial GAS T‐scores. Following at least 4 BoNT injection cycles, patients were reassessed whether they reached the pre‐set goals.ResultsThe initial GAS T‐scores (median: 36.9, range: 22.8–40) significantly improved (P < 0.001) to the end of the study (the median of final GAS T‐scores: 50, range: 25.5–63.6).ConclusionsThe applicability of GAS in CD patients was confirmed, but further large‐scale studies are needed refining this innovative approach.